What is OrSense?
OrSense is a specialized medical device enterprise focused on the development and commercialization of Occlusion Spectroscopy. Its core innovation, the SpectOLight technology, facilitates the non-invasive measurement of hemoglobin and oxygen saturation levels. By effectively mitigating the performance limitations inherent in traditional monitoring systems, the company provides clinicians with reliable data even under challenging physiological conditions. This technological edge positions OrSense as a vital contributor to the evolution of patient monitoring, bridging the gap between invasive accuracy and non-invasive convenience in clinical settings.
How much funding has OrSense raised?
OrSense has raised a total of $26.2M across 2 funding rounds:
Private Equity
$8.2M
Unspecified
$18M
Private Equity (2001): $8.2M, investors not publicly disclosed
Unspecified (2011): $18M led by Israel Healthcare Ventures and Star Ventures
Key Investors in OrSense
Israel Healthcare Ventures
A prominent Israeli life sciences venture fund that provides hands-on management support and strategic guidance to companies in the cardiology, oncology, and medical device sectors.
Star Ventures
An investment entity that maintains a diverse portfolio, contributing to the operational framework and growth initiatives of its partner companies.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for OrSense?
With this recent infusion of capital, OrSense is well-positioned to accelerate its commercialization efforts and expand the reach of its SpectOLight platform. The strategic focus will likely shift toward scaling manufacturing capabilities and deepening market penetration within global healthcare systems. As the company transitions into a more mature operational phase, the emphasis will remain on securing regulatory milestones and fostering partnerships that validate the clinical utility of its non-invasive monitoring suite. This financial backing provides the necessary runway to refine its product roadmap and address unmet needs in critical care and surgical monitoring environments.
See full OrSense company page
